Filter by ContentType
mRNA combination vaccines for respiratory infections: the developer’s view
Francesca Ceddia
19 February 2025
Interview
The case for combination vaccines
William Hausdorff
12 February 2025
Interview
Harnessing high-throughput approaches for bacterial vaccine development
Fadil Bidmos
07 February 2025
Interview
From Ebola to Mpox: developing International Standards to accelerate vaccine development
Giada Mattiuzzo
09 December 2024
Interview
Understanding DNA starting material for mRNA production
Lawrence Thompson
30 October 2024
Interview
Developing new RNA vaccine formulations to target non-enveloped viruses and boost mucosal responses
Jesse Erasmus
10 October 2024
Interview
Vaccinating cattle against H5N1: challenges and benefits
Alan Young
26 September 2024
Interview
One Health approaches to vaccine development in the post-pandemic era
Trina Racine
13 September 2024
Interview
Enhancing vaccine trials across Europe and beyond
Pierre Van Damme
12 September 2024
Interview
Developing new nanocage-based systems for multivalent vaccine delivery
Kourosh Ebrahimi, Yujie Sheng
06 August 2024
Interview
HIV vaccine research at Gates Foundation: mRNA and beyond
Pervin Anklesaria
31 July 2024
Interview
Delving into the unknowns of mRNA-LNP formulation and characterization
Ramesh Marasini
15 July 2024
Interview
Clinical assays for vaccine development: the role of CEPI centralized laboratory network
Ali Azizi
25 June 2024
Interview
Taking a high-throughput approach to enhancing the target specificity and stability of nanoparticles
Chun-Wan Yen, Yuchen Fan
20 June 2024
Interview
Evolution of mRNA-based vaccines: a regulator’s view
Ka-Wai Wan
22 May 2024
Interview
Is there a role for vaccines in combatting the opioid epidemic?
Elizabeth Norton
09 May 2024
Interview
Technical development and manufacturing of vaccines in the context of worldwide regulatory requirements
Olga Rovira
17 April 2024
Interview
Maintaining ‘warm base’ capacity for pandemic preparedness
Kilian Mullett
12 April 2024
Interview
Revolutionizing cancer treatment? A conversation on the potential of personalized cancer vaccines
Roy de Souza, David Hawke
20 March 2024
Interview
Combination therapies: a journey into personalized vaccine immunotherapeutics for early-stage cancers
Stephen Johnston
06 March 2024
Interview
Focusing on the fundamentals: what do and don’t we know about mRNA delivery?
Colin Pouton, Angus Johnston
04 March 2024
Interview